Search

Headquarters

Contact Us

  • (+01) 512 835 8026
  • info@myriadrbm.com
  • 3300 Duval Road
    Austin, TX 78759
    USA
  • Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started

  • (+01) 512 835 8026
  • info@myriadrbm.com
Get a Quote Contact | FAQ's | Blog
Myriad RBM Myriad RBM

Innovative Biomarker Solutions

Toggle menu

Skip to content
  • About Us

    • About Myriad RBM

      Myriad RBM’s CLIA certified biomarker testing laboratory, is located in Austin, TX. Myriad RBM is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN), a leading molecular diagnostic company based in Salt Lake City, Utah which develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests.

    • About Myriad RBM

      • About Us
      • Management
      • Quality Policy
      • Employment
      • Partners
      • Sales Team
      • Certifications

    • Newsroom

      • Press
      • Company Newsletters
      • Conferences
      • Abstracts + Papers
      • Sign Up for Our Newsletter
      • Blog

    • Data Quality

      • Overview
      • Myriad RBM Technology
  • Biomarker Solutions

    • Solutions

      • Overview
      • Assay Change Log

      CustomMAP

      If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.

      Learn More »

      TruCulture Spike

    • Multiplexed Immunoassays

      • Full Biomarker Menu
      • DiscoveryMAP® v. 4.0
      • ExplorerMAP™ v. 1.0
      • HumanMAP® v. 2.0
      • CardiovascularMAP® v. 3.0
      • AngiogenesisMAP® v. 1.0
      • InflammationMAP® v. 1.1
      • ImmunoMAP® v. 1.0
      • MetabolicMAP® v. 1.0
      • KidneyMAP®
      • CytokineMAP A
      • CytokineMAP B
      • SARS-CoV-2/COVID-19 Research
      • Cytokine Storm Testing for SARS-CoV-2/COVID-19 Research
      • SARS-CoV-2 Multiplex Serology
      Webinar Registration
    • TruCulture

      Whole Blood Collection and Culture System

      Learn More »
      Quanterix simoa

      Ultrasensitive immunoassays manufactured by Myriad RBM and based on Quanterix’s Simoa technology.

      Learn More »
  • Resources + Support

    • Resources

      • Bibliography
      • White Papers
      • Application Notes
      • Events
      • Webinars
      • Blog
      • COVID-19/SARS-CoV-2 Research Tools

    • Support

      • Client Services
      • Request a Biomarker
      • Speak to a Scientist
  • How to Order

    • Ordering Information

      • How to Order
      • Request a quote
      • Acceptable Samples
      • Frequently Asked Questions

    • Request Information

      • Contact Client Services
      • Request a Biomarker
      • Speak to a Scientist

    • Ready to Order?

      Great!

      Every order starts with a quote.

      Get Started

  •  

Category Archives: Utilized Myriad RBM’s Services

15 Sep 2014

Blood-based proteins are crucial to the development of biomarker tests aimed at improving the diagnosis and treatment of psychiatric disorders

September 15, 2014
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological, Utilized Myriad RBM's Services
A recent review of studies measuring proteins in blood serum/plasma illustrates the systemic nature of disease-related changes in patients with schizo...
Read More
29 Aug 2014

Biomarker signatures predict clinical outcomes in metastatic colorectal cancer (mCRC) patients treated with chemotherapy and cediranib

August 29, 2014
myriadrbm
Blog, Cancer, Utilized Myriad RBM's Services
Researchers sought to explore biomarkers in pre- and on- treatment mCRC patients receiving chemotherapy with and without cediranib, in order to identi...
Read More
21 Aug 2014

Vitamin D Binding Protein in serum demonstrates utility as a biomarker of Alzheimer’s disease

August 21, 2014
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological, Utilized Myriad RBM's Services
Researchers at the University of Texas Health Science Center, San Antonio used a Multiple Indicators Multiple Causes (MIMIC) approach to evaluate the...
Read More
13 Aug 2014

Blood-based proteins help elucidate mediators of cognitive impairment in Late Life Depression (LLD)

August 13, 2014
Desiree Klingler-Gaston
Blog, Neuroscience and Neurological, Utilized Myriad RBM's Services
Researchers from the University of Pittsburgh analyzed 242 proteins in conjunction with structural brain abnormalities to identify biological mechanis...
Read More
7 Aug 2014

Biomarkers enhance prediction of cardiovascular events when added to clinical risk factors in the ORIGIN trial

August 7, 2014
Desiree Klingler-Gaston
Blog, Cardiac, Utilized Myriad RBM's Services
Measuring large numbers of biomarkers in blood with new assay technologies may identify new biomarkers and physiologic pathways for cardiovascular eve...
Read More
3 Jun 2014

Inflammatory Proteins Hold Promise as Early Predictors of Psychosis

June 3, 2014
Desiree Klingler-Gaston
Blog, Inflammation, Neuroscience and Neurological, Utilized Myriad RBM's Services
Researchers at Johns Hopkins University published data suggesting that a panel of inflammatory proteins measured in blood may be useful in identifying...
Read More
27 May 2014

Recorded Webinar: Standardized Assays for Personalized Immune Response Monitoring

May 27, 2014
Desiree Klingler-Gaston
Blog, Inflammation, Utilized Myriad RBM's Services
If you were unable to attend the webinar or would like to view the webinar again, a recorded version is now available for your convenience. This onlin...
Read More
1 2 3 4 5 6 7

Categories

  • Biomarkers (4)
  • Blog (134)
    • Autoimmune and Arthritis (10)
    • Cancer (28)
    • Cardiac (9)
    • Cytokines and Chemokines (20)
    • Diabetes (7)
    • Gastrointestinal (1)
    • Inflammation (42)
    • Neuroscience and Neurological (33)
    • News From the Lab (1)
    • Renal Function and Toxicity (8)
    • Technology- Multi-Analyte Profile (1)
    • TruCulture (2)
  • COVID-19 (1)
  • Press (37)
  • Utilized Myriad RBM's Services (43)

ABOUT MYRIAD RBM

Overview
Management
Quality Policy
Employment
Partners
Sales Team
Certifications

MAPs

Full Biomarker Menu
DiscoveryMAP® v. 3.3
ExplorerMAP™ v. 1.0
HumanMAP® v. 2.0
CardiovascularMAP® v. 3.0
AngiogenesisMAP® v. 1.0
InflammationMAP® v. 1.0
ImmunoMAP® v. 1.0
NeuroMAP™ v. 1.0
MetabolicMAP® v. 1.0
KidneyMAP®
CytokineMAP A
CytokineMAP B

RESOURCES

Bibliography
White Papers
Events
Webinars
Blog

SUPPORT

Customer Support
Speak to a Scientist
Assay Change Log
Request a Biomarker
FAQs

SOLUTIONS

Results Processing
Assay Development
Quality Control
Project Management

SERVICES

Multiplexed Assay Services
Ultrasensitive Assays
TruCulture

  • Jobs
  • Terms of Use
  • Privacy Practice
  • Analytes Listing
Copyright © 2021 Myriad RBM. All rights reserved. Myriad does not sell your personal information